IN8bio, Inc. (INAB) vs Kiora Pharmaceuticals, Inc. (KPRX)
IN8bio, Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. IN8bio, Inc. and Kiora Pharmaceuticals, Inc. are of similar size ($11.8M and $11.1M). Across the 10 metrics below, Kiora Pharmaceuticals, Inc. leads on 8 and IN8bio, Inc. on 2.
Valuation
Profitability
| Metric | INAB | KPRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 85.06% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (111.11%) | (56.36%) | (57.72%) |
| Return on assets | (90.80%) | (39.43%) | (49.22%) |
| Return on invested capital | (2,948.56%) | (44,053.91%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack